Industry Placement to Evaluate Porcine Skin as a Model for Human Biofilm Research Dec 1, 2021 - Mar 31, 2022
Projects (504)
The epigenetic regulatory protein CBX2 as a novel therapeutic target for glioblastoma multiform Sep 19, 2022 - Sep 18, 2025
PhD Studentship:
Glioblastoma (GBM) is the deadliest form of brain tumour, affecting 2-3 per 100,000 people each year. The average length of survival for GBM remain low at only 12-15 months following diagnosis, in part, due to a lack of targeted t...
Read More about The epigenetic regulatory protein CBX2 as a novel therapeutic target for glioblastoma multiform.
UKRI Covid 19 Extension Pot - Global analysis of molecular changes in head and neck squamous cell carcinoma (HNSCC) tissue maintained and treated on microfluidic devices Jul 1, 2020 - Sep 30, 2021
The technician employed (0.5 FTE) on the grant started work at the Daisy Laboratories, Castle Hill Hospital, on 2nd March 2020 and was trained on all of the techniques necessary. However, due to the onset of Covid-19 only one tumour sample was obtai...
Read More about UKRI Covid 19 Extension Pot - Global analysis of molecular changes in head and neck squamous cell carcinoma (HNSCC) tissue maintained and treated on microfluidic devices.
Extracorporeal shockwave therapy compared to best available treatment for patients with intermittent claudication - NIHR RDS PPI Application Nov 28, 2021 - Apr 1, 2022
NIHR RDS Application for funding to support PPI work to strengthen an NIHR grant application .
EARLY DIAPAC: EARLY DIAgnosis of PAncreatic Cancer by combined proteomics and genomics testing of pancreatic cyst fluid. Dec 1, 2022 - Dec 31, 2024
This is part of a total project cost of £98,508.70.
BREATHE-INDIA: BREATHlEssness in INDIA - Development of a breathlessness beliefs and behaviour education intervention for use in the community-setting Oct 1, 2022 - Mar 31, 2024
PUBLIC HEALTH CHALLENGE: Chronic (persistent) breathlessness despite treatment of causal disease(s) 1 is associated with disability and a vicious cycle of avoiding physical activity-related breathlessness,2 deconditioning and increasing breathlessnes...
Read More about BREATHE-INDIA: BREATHlEssness in INDIA - Development of a breathlessness beliefs and behaviour education intervention for use in the community-setting.
Catch up HPV screening project Apr 1, 2022 - Mar 31, 2027
In 2019, HPV testing replaced cytology (a smear) as the first (primary) cervical screening test. This project will offer a catch-up HPV test to women now aged 65-79 who exited the screening programme before ever having a primary HPV test. This will i...
Read More about Catch up HPV screening project.
Updating (Reviewing and Printing) the Patient's Guide to Pulmonary Fibrosis. Nov 1, 2022 - Oct 31, 2023
This is an annual follow up/annual review for the Project 3632727: Development And Publication Of The Booklet For The Pulmonary Fibrosis (disease With A Degree Of Similarity To Coronavirus Disease).
Chronic diseases associated with fibrosis pres...
Read More about Updating (Reviewing and Printing) the Patient's Guide to Pulmonary Fibrosis..
Programme of Research for Alcohol Care Teams: Impact, Value and Effectiveness (ProACTIVE -2) Oct 1, 2022 - May 31, 2027
Alcohol-related hospital admissions continue to rise, with estimates that 10% of patients admitted to acute hospitals may be alcohol dependent (AD). Yet, there remains considerable variation in provision of Alcohol Care Teams (ACTs) in England, and a...
Read More about Programme of Research for Alcohol Care Teams: Impact, Value and Effectiveness (ProACTIVE -2).
Living well with chronic breathlessness: Improving the sustainable use of supported self-management strategies Mar 1, 2023 - Dec 31, 2024
Chronic (persistent) breathlessness restricts social lives and day-to-day tasks. Breathlessness services can support people to self-manage, but there is often a gap between knowing what to do and doing it - true for patients, carers and clinicians al...
Read More about Living well with chronic breathlessness: Improving the sustainable use of supported self-management strategies.
Using novel endolysins to selectively target antimicrobial resistant S. aureus in chronic wound biofilms Jan 1, 2023 - Dec 31, 2026
This cutting-edge PhD project will bring together a world-leading team spanning industry and academia, providing an interdisciplinary framework to explore the selectivity and efficacy of endolysin against clinically meaningful S. aureus wound biofilm...
Read More about Using novel endolysins to selectively target antimicrobial resistant S. aureus in chronic wound biofilms.
Understanding interaction in problematic dementia and social care encounters Nov 1, 2022 - Apr 30, 2024
It is well established that care-home workers have a far-reaching influence on the well-being of the people they look after. However, they are a section of the healthcare workforce that has traditionally been under-valued and under-trained. This stud...
Read More about Understanding interaction in problematic dementia and social care encounters.
Identification of targets for the therapy of epithelial ovarian cancer Mar 1, 2022 - Feb 28, 2023
Finding provided by the INSPIRE grant generously awarded to the Hull York Medical School by the Academy of Medical Sciences through the Wellcome Trust [Ref: IR5\1018]
A cell model for discovering biomarkers and druggable targets for pulmonary fibrosis May 1, 2023 - Jan 31, 2025
Effect of hypoxia on prostacyclin-mediated inhibition of platelet function Jan 1, 2023 - Dec 31, 2025
Tissue hypoxia occurs in multiple cardiovascular and pulmonary conditions that have platelet activation or hyperreactivity, including myocardial infarction, stroke, chronic obstructive pulmonary disease (COPD) and sleep apnoea. However, knowledge on...
Read More about Effect of hypoxia on prostacyclin-mediated inhibition of platelet function.
THIS Institute PhD Fellowship application Oct 1, 2023 - Sep 30, 2027
PhD Fellowship: Improving patient and carer outcomes through integration of patient and family values with service provision.
THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment (THRIVE) Oct 1, 2023 - Dec 31, 2026
THRomboprophylaxis in Individuals undergoing superficial endoVEnous therapy (THRIVE), a multi-centre assessor-blind randomised-controlled trial